CRM
AGN
Cramer Rosenthal McGlynn’s Allergan plc AGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-385,064
| Closed | -$56.4M | – | 133 |
|
|
2019
Q1 | $56.4M | Buy |
385,064
+50,166
| +15% | +$7.34M | 1.34% | 23 |
|
|
2018
Q4 | $44.8M | Sell |
334,898
-118,625
| -26% | -$15.9M | 1.13% | 34 |
|
|
2018
Q3 | $86.4M | Sell |
453,523
-188,766
| -29% | -$36M | 1.65% | 10 |
|
|
2018
Q2 | $107M | Sell |
642,289
-55,962
| -8% | -$9.33M | 1.92% | 3 |
|
|
2018
Q1 | $118M | Buy |
698,251
+92,992
| +15% | +$15.6M | 1.92% | 4 |
|
|
2017
Q4 | $99M | Buy |
605,259
+179,489
| +42% | +$29.4M | 1.59% | 7 |
|
|
2017
Q3 | $87.3M | Buy |
425,770
+145,099
| +52% | +$29.7M | 1.4% | 14 |
|
|
2017
Q2 | $68.2M | Buy |
280,671
+9,726
| +4% | +$2.36M | 1.04% | 26 |
|
|
2017
Q1 | $64.7M | Sell |
270,945
-258,380
| -49% | -$61.7M | 0.99% | 27 |
|
|
2016
Q4 | $111M | Buy |
529,325
+216,533
| +69% | +$45.5M | 1.65% | 4 |
|
|
2016
Q3 | $72M | Sell |
312,792
-55,351
| -15% | -$12.7M | 1.11% | 15 |
|
|
2016
Q2 | $85.1M | Buy |
368,143
+150,269
| +69% | +$34.7M | 1.37% | 6 |
|
|
2016
Q1 | $58.4M | Buy |
217,874
+9,496
| +5% | +$2.55M | 0.92% | 34 |
|
|
2015
Q4 | $65.1M | Buy |
208,378
+103,438
| +99% | +$32.3M | 0.98% | 30 |
|
|
2015
Q3 | $28.5M | Sell |
104,940
-15,965
| -13% | -$4.34M | 0.38% | 100 |
|
|
2015
Q2 | $36.7M | Sell |
120,905
-9,990
| -8% | -$3.03M | 0.45% | 99 |
|
|
2015
Q1 | $39M | Buy |
130,895
+86,295
| +193% | +$25.7M | 0.44% | 100 |
|
|
2014
Q4 | $11.5M | Buy |
+44,600
| New | +$11.5M | 0.12% | 159 |
|